Literature DB >> 15355915

p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population.

J Shawn Jones1, Xuedong Chi, Xiangjun Gu, Patrick M Lynch, Christopher I Amos, Marsha L Frazier.   

Abstract

PURPOSE: Hereditary nonpolyposis colorectal cancer (HNPCC) is an autosomal dominant syndrome of familial malignancies. Colorectal and endometrial cancers are most frequently observed. The syndrome results mainly from germ-line mutations in DNA mismatch repair genes. A common G-to-C polymorphism at codon 72 in the p53 gene has been associated with increased risk for lung, nasopharyngeal, oral, prostate, and breast cancers and may be a marker for genetic susceptibility to colorectal cancer. We studied the influence of this p53 polymorphism on HNPCC age of onset. EXPERIMENTAL
DESIGN: We determined the p53 genotype of 92 Caucasian mismatch repair mutation carriers, of which, 47 had colorectal cancer. The subjects were genotyped by single-strand conformational polymorphism analysis. We tested the association between age of onset and the p53 genotypes by comparing Kaplan-Meier survival curves, evaluating the homogeneity of the curves using the log-rank test and Wilcoxon's test, and estimating the association using the Cox proportional hazards regression model to adjust for potential demographic confounding factors.
RESULTS: The HNPCC patients who were heterozygous developed their colorectal cancer 13 years earlier than HNPCC patients who were homozygous for the wild-type allele.
CONCLUSIONS: Combining knowledge of an individual's p53 genotype with information on other genetic and environmental risk factors may improve risk estimates and help to identify individuals who are genetically susceptible to developing HNPCC at an earlier age.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15355915     DOI: 10.1158/1078-0432.CCR-03-0590

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  25 in total

Review 1.  Molecular basis for subdividing hereditary colon cancer?

Authors:  W M Grady
Journal:  Gut       Date:  2005-12       Impact factor: 23.059

2.  Potential genotype-specific single nucleotide polymorphism interaction of common variation in p53 and its negative regulator mdm2 in cholangiocarcinoma susceptibility.

Authors:  Vincent Zimmer; Aksana Höblinger; Florentina Mihalache; Gunter Assmann; Monica Acalovschi; Frank Lammert
Journal:  Oncol Lett       Date:  2012-04-17       Impact factor: 2.967

3.  MSH6 and PMS2 mutation positive Australian Lynch syndrome families: novel mutations, cancer risk and age of diagnosis of colorectal cancer.

Authors:  Bente A Talseth-Palmer; Mary McPhillips; Claire Groombridge; Allan Spigelman; Rodney J Scott
Journal:  Hered Cancer Clin Pract       Date:  2010-05-21       Impact factor: 2.857

4.  Identification of TRIML2, a novel p53 target, that enhances p53 SUMOylation and regulates the transactivation of proapoptotic genes.

Authors:  Che-Pei Kung; Sakina Khaku; Matthew Jennis; Yan Zhou; Maureen E Murphy
Journal:  Mol Cancer Res       Date:  2014-09-25       Impact factor: 5.852

5.  MDM2 SNP309 accelerates colorectal tumour formation in women.

Authors:  Gareth L Bond; Chiara Menin; Roberta Bertorelle; Pia Alhopuro; Lauri A Aaltonen; Arnold J Levine
Journal:  J Med Genet       Date:  2006-07-06       Impact factor: 6.318

Review 6.  Lynch syndrome (hereditary non-polyposis colorectal cancer): current concepts and approaches to management.

Authors:  Luigi Ricciardiello; C Richard Boland
Journal:  Curr Gastroenterol Rep       Date:  2005-10

7.  Genetic variants in germline TP53 and MDM2 SNP309 are not associated with early onset colorectal cancer.

Authors:  Sajid A Khan; Kamran Idrees; Ann Forslund; Zhaoshi Zeng; Shoshana Rosenberg; Hanna Pincas; Francis Barany; Kenneth Offit; Michael P Laquaglia; Philip B Paty
Journal:  J Surg Oncol       Date:  2008-06-01       Impact factor: 3.454

8.  Genetic variants in the cell cycle control pathways contribute to early onset colorectal cancer in Lynch syndrome.

Authors:  Jinyun Chen; Carol J Etzel; Christopher I Amos; Qing Zhang; Nancy Viscofsky; Noralane M Lindor; Patrick M Lynch; Marsha L Frazier
Journal:  Cancer Causes Control       Date:  2009-08-19       Impact factor: 2.506

9.  Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans.

Authors:  Charles C Weige; Marc R Birtwistle; Himel Mallick; Nengjun Yi; Zuzana Berrong; Emily Cloessner; Keely Duff; Josephine Tidwell; Megan Clendenning; Brent Wilkerson; Christopher Farrell; Fred Bunz; Hao Ji; Michael Shtutman; Kim E Creek; Carolyn E Banister; Phillip J Buckhaults
Journal:  Mol Cancer Res       Date:  2014-04-17       Impact factor: 5.852

10.  Cell cycle-related genes as modifiers of age of onset of colorectal cancer in Lynch syndrome: a large-scale study in non-Hispanic white patients.

Authors:  Jinyun Chen; Mala Pande; Yu-Jing Huang; Chongjuan Wei; Christopher I Amos; Bente A Talseth-Palmer; Cliff J Meldrum; Wei V Chen; Ivan P Gorlov; Patrick M Lynch; Rodney J Scott; Marsha L Frazier
Journal:  Carcinogenesis       Date:  2012-11-03       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.